Literature DB >> 27708879

An old disease with new insights: Update on diagnosis and treatment of gout.

Berivan Bitik1, M Akif Öztürk1.   

Abstract

Gout is an acute and chronic inflammatory disorder associated with high morbidity and impaired quality of life. There has been a substantial increase in the prevalence and incidence of gout in recent years. Novel diagnostic and therapeutic options have provided new insights into the pathogenesis and management of hyperuricemia and gout in the last decade. This clinical review aims to summarize the diagnostic process and management of acute and chronic gout.

Entities:  

Keywords:  Gout; diagnosis; treatment

Year:  2014        PMID： 27708879      PMCID： PMC5042282          DOI： 10.5152/eurjrheumatol.2014.021

Source DB:  PubMed          Journal:  Eur J Rheumatol        ISSN： 2147-9720


  104 in total

1.  Diagnostic imaging of gout: comparison of high-resolution US versus conventional X-ray.

Authors:  Thomas Rettenbacher; Sybille Ennemoser; Harald Weirich; Hanno Ulmer; Frank Hartig; Werner Klotz; Manfred Herold
Journal:  Eur Radiol       Date:  2007-11-10       Impact factor: 5.315

Review 2.  The distribution of urate deposition within the extremities in gout: a review of 148 dual-energy CT cases.

Authors:  Paul I Mallinson; Adrian C Reagan; Tyler Coupal; Peter L Munk; Hugue Ouellette; Savvas Nicolaou
Journal:  Skeletal Radiol       Date:  2013-12-12       Impact factor: 2.199

3.  Rilonacept (interleukin-1 trap) for prevention of gout flares during initiation of uric acid-lowering therapy: results from a phase III randomized, double-blind, placebo-controlled, confirmatory efficacy study.

Authors:  H Ralph Schumacher; Robert R Evans; Kenneth G Saag; James Clower; William Jennings; Steven P Weinstein; George D Yancopoulos; Jian Wang; Robert Terkeltaub
Journal:  Arthritis Care Res (Hoboken)       Date:  2012-10       Impact factor: 4.794

4.  Colchicine for prophylaxis of acute flares when initiating allopurinol for chronic gouty arthritis.

Authors:  Gregory C Borstad; Leslie R Bryant; Michael P Abel; Daren A Scroggie; Mark D Harris; Jeff A Alloway
Journal:  J Rheumatol       Date:  2004-12       Impact factor: 4.666

5.  Ultrasonographic measurement of tophi as an outcome measure for chronic gout.

Authors:  Fernando Perez-Ruiz; Iñaki Martin; Begoña Canteli
Journal:  J Rheumatol       Date:  2007-07-15       Impact factor: 4.666

6.  Purine-rich foods, dairy and protein intake, and the risk of gout in men.

Authors:  Hyon K Choi; Karen Atkinson; Elizabeth W Karlson; Walter Willett; Gary Curhan
Journal:  N Engl J Med       Date:  2004-03-11       Impact factor: 91.245

7.  Asymptomatic hyperuricemia. Risks and consequences in the Normative Aging Study.

Authors:  E W Campion; R J Glynn; L O DeLabry
Journal:  Am J Med       Date:  1987-03       Impact factor: 4.965

8.  Soft drinks, fructose consumption, and the risk of gout in men: prospective cohort study.

Authors:  Hyon K Choi; Gary Curhan
Journal:  BMJ       Date:  2008-01-31

9.  Reduction of plasma urate levels following treatment with multiple doses of pegloticase (polyethylene glycol-conjugated uricase) in patients with treatment-failure gout: results of a phase II randomized study.

Authors:  John S Sundy; Michael A Becker; Herbert S B Baraf; Andre Barkhuizen; Larry W Moreland; William Huang; Royce W Waltrip; Allan N Maroli; Zeb Horowitz
Journal:  Arthritis Rheum       Date:  2008-09

10.  Persistence of monosodium urate crystals and low-grade inflammation in the synovial fluid of patients with untreated gout.

Authors:  E Pascual
Journal:  Arthritis Rheum       Date:  1991-02
View more
  5 in total

1.  Gouty tophi with purpura in a patient with ischemic heart disease and acute kidney injury.

Authors:  Manoj Karbhari Pawar
Journal:  Eur J Rheumatol       Date:  2017-10-25

2.  Place of orthopedic surgery in gout.

Authors:  Recep Öztürk; İsmail Burak Atalay; Emin Kürşat Bulut; Galip Beltir; Selçuk Yılmaz; Bedii Şafak Güngör
Journal:  Eur J Rheumatol       Date:  2019-09-05

3.  Recombinant human proteoglycan-4 reduces phagocytosis of urate crystals and downstream nuclear factor kappa B and inflammasome activation and production of cytokines and chemokines in human and murine macrophages.

Authors:  Marwa Qadri; Gregory D Jay; Ling X Zhang; Wendy Wong; Anthony M Reginato; Changqi Sun; Tannin A Schmidt; Khaled A Elsaid
Journal:  Arthritis Res Ther       Date:  2018-08-29       Impact factor: 5.156

4.  Design and Biological Evaluation of Colchicine-CD44-Targeted Peptide Conjugate in an In Vitro Model of Crystal Induced Inflammation.

Authors:  Khalid A Zoghebi; Emira Bousoik; Keykavous Parang; Khaled A Elsaid
Journal:  Molecules       Date:  2019-12-21       Impact factor: 4.411

5.  CD44 Receptor Mediates Urate Crystal Phagocytosis by Macrophages and Regulates Inflammation in A Murine Peritoneal Model of Acute Gout.

Authors:  Emira Bousoik; Marwa Qadri; Khaled A Elsaid
Journal:  Sci Rep       Date:  2020-04-01       Impact factor: 4.379
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.